Dr Peter V Vaitkevicius, MD | |
18181 Oakwood Blvd, Suite 101, Dearborn, MI 48124-0000 | |
(313) 996-7280 | |
Not Available |
Full Name | Dr Peter V Vaitkevicius |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 40 Years |
Location | 18181 Oakwood Blvd, Dearborn, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477590461 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Aspirus Keweenaw Hospital And Clinics | Laurium, MI | Hospital |
Aspirus Ontonagon Hospital Inc | Ontonagon, MI | Hospital |
Aspirus Wausau Hospital | Wausau, WI | Hospital |
Baraga County Memorial Hospital | L' anse, MI | Hospital |
Aspirus Ironwood Hospital | Ironwood, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aspirus Medical Group Inc | 1052223625 | 212 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Entity Name | Baraga County Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851409643 PECOS PAC ID: 7416866611 Enrollment ID: O20040826000560 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Entity Name | Baraga County Memorial Hospital |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1558479824 PECOS PAC ID: 7416866611 Enrollment ID: O20100913001031 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Entity Name | Aspirus Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568765550 PECOS PAC ID: 1052223625 Enrollment ID: O20110914000072 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Entity Name | Aspirus Wausau Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174601876 PECOS PAC ID: 6406757442 Enrollment ID: O20120330000158 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Peter V Vaitkevicius, MD 18181 Oakwood Blved, Suite 101, Dearborn, MI 48124 Ph: (313) 996-7280 | Dr Peter V Vaitkevicius, MD 18181 Oakwood Blvd, Suite 101, Dearborn, MI 48124-0000 Ph: (313) 996-7280 |
News Archive
Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, South Dakota, knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University.
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.
In the battle between humans and infectious bacteria, humans have had the advantage, at least since antibiotics were introduced into our arsenal 70 or so years ago. Now, however, our weapons appear to be turning against us as germs have found ways to outfox antibiotics…. A second challenge is to keep a steady stream of new antibiotics in the pipeline, and this is where the big pharmaceutical companies based in Europe and the U.S. come in….
Individuals who had cancer as a child may be at increased risk of being obese due to the therapies they received during their youth. The finding comes from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest the need for effective counseling and weight loss interventions for certain childhood cancer survivors.
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
› Verified 6 days ago
Albagir Mohamed Alarabi, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Rama V Thyagarajan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd Ste 101, Medical Office Building, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 | |
Adeeb M Atassi, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 18181 Oakwood Blvd, Suite Number 208, Dearborn, MI 48124 Phone: 313-563-3332 | |
Mihaela A. Lupu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 208, Dearborn, MI 48124 Phone: 313-271-5670 Fax: 313-271-1053 | |
Violet Asfour, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 18100 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2578 | |
Raed Haddad, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9720 Dix, Ste B, Dearborn, MI 48120 Phone: 313-843-1973 Fax: 313-843-1961 | |
Dr. Denise Kirsch, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd Ste 101, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 |